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PTPMT1 was the first protein tyrosine phosphatase
found localized to themitochondria, but its biological
function was unknown. Herein, we demonstrate
that whole body deletion of Ptpmt1 in mice leads to
embryonic lethality, suggesting an indispensable
role for PTPMT1 during development. Ptpmt1 defi-
ciency inmouse embryonic fibroblasts compromises
mitochondrial respiration and results in abnormal
mitochondrial morphology. Lipid analysis of Ptpmt1-
deficient fibroblasts reveals an accumulation of
phosphatidylglycerophosphate (PGP) along with
a concomitant decrease in phosphatidylglycerol.
PGP is an essential intermediate in the biosynthetic
pathway of cardiolipin, a mitochondrial-specific
phospholipid regulating the membrane integrity and
activities of the organelle. We further demonstrate
that PTPMT1 specifically dephosphorylates PGP
in vitro. Loss of PTPMT1 leads to dramatic diminu-
tion of cardiolipin, which can be partially reversed
by the expression of catalytic active PTPMT1. Our
study identifies PTPMT1 as the mammalian PGP
phosphatase and points to its role as a regulator of
cardiolipin biosynthesis.
INTRODUCTION
Reversible phosphorylation is a major regulatory mechanism
controlled by more than 500 kinases and 100 phosphatases
(Alonso et al., 2004; Manning et al., 2002). Although the majority
of kinases and phosphatases function on protein substrates,
there are notable examples of kinases and phosphatases that
regulate the production and breakdown of phospholipids. For
instance, phosphoinositide 3-kinase (PI3K) and PTEN are two
enzymes that regulate the abundance of key cellular phospho-
lipids (Maehama and Dixon, 1998; Whitman et al., 1988). The690 Cell Metabolism 13, 690–700, June 8, 2011 ª2011 Elsevier Inc.importance of PTEN in tumor biology prompted us to identify
additional phosphatases similar to PTEN (Pagliarini et al.,
2004). We used the amino acid sequence surrounding the active
site, HCKAGKGR, which includes two invariant basic amino
acids (bold) along with the catalytically essential Cys-X5-Arg
(CX5R) motif, to search for closely related phosphatases. To
our surprise, we discovered a protein tyrosine phosphatase
(PTP) that localized exclusively to the inner mitochondrial
membrane (Pagliarini et al., 2005). This was the first CX5R
phosphatase found in mitochondria, and, because of its unique
localization, we named it PTPMT1 (PTP localized to the
mitochondrion 1). This phosphatase is highly conserved and is
present in animals, plants, and bacteria (Pagliarini et al., 2004).
Mitochondria are ubiquitous and dynamic organelles that
participate in crucial cellular processes in eukaryotic organisms.
They are responsible for the production of over 90% of cellular
ATP (Voet and Voet, 2004). Mitochondria are also the sites of
fatty acid oxidation, ketone body production, heme biosyn-
thesis, cardiolipin metabolism, and coenzyme Q synthesis. In
addition, mitochondria are a major source of reactive oxygen
species. They harbor key steps of gluconeogenesis and the
urea cycle and are central to themechanisms of apoptosis (New-
meyer and Ferguson-Miller, 2003; Voet and Voet, 2004).
Due to the unique localization of PTPMT1 in the inner mito-
chondrial membrane, we postulated that it plays important roles
in oxidative phosphorylation or other mitochondrial functions.
Therefore, we sought to elucidate the cellular function(s) and
identify the endogenous substrate(s) of this phosphatase.RESULTS
Inactivation of the Ptpmt1 Gene Leads to Embryonic
Lethality
To study the physiological function(s) of PTPMT1, we genetically
engineered mice in which the Ptpmt1 gene was ablated through
homologous recombination (Figure 1A). Subsequently, we inter-
crossed Ptpmt1-heterozygous mice to examine the conse-
quences of PTPMT1 deficiency. Out of 173 offspring born,
66 were wild-type, 107 were heterozygous, and none were
Figure 1. Inactivation of the Ptpmt1 Gene Leads to Mouse Embry-
onic Lethality
(A) Gene targeting strategy. Exons (blue boxes), translation initiation site (ATG),
selection gene (neomycin, neo), positions of 50 and 30 probes for Southern blot
(red bars), PCR primer (red arrows), loxP sites (blue triangles), Frt sites (green
triangles), and restriction sites are indicated. X-XbaI, E-EcoRI.
(B) Genotype of offspring from Ptpmt1 heterozygous intercrosses at various
developmental stages.
(C) Derivation of Ptpmt1-deficient mouse embryonic fibroblasts. Ptpmt1flox/flox
MEFs were infected with recombinant adenoviruses encoding GFP(–) or
GFP-Cre (+). Cells were harvested at the indicated time points postinfection for
western blot analysis. dpi, days postinfection.
See also Figure S1.
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detailed characterization of mouse genotyping), indicating
a Mendelian ratio typical of embryonic lethality. We next con-
ducted timed mating experiments to determine the stage of
the embryonic lethality. Embryos from E8.5, E10.5, E14.5, and
E17.5–18.5 gestational stages were primarily wild-type or
heterozygous for thePtpmt1 allele (Figure 1B). Further dissection
identified an average of 26% resorption sites on the uterus
lacking discernible embryos from all developmental stages
(Figure 1B), suggesting that Ptpmt1–/– embryos implanted but
died prior to E8.5. Hence, our results suggest that PTPMT1 plays
an indispensable role in early development.CInhibition of Mitochondrial Respiration in Cells Lacking
PTPMT1
To further investigate the physiological functions of PTPMT1, we
generated a floxed allele of Ptpmt1 in mice for Cre-mediated
conditional knockout (Ptpmt1+/flox) (Figure 1A and Figure S1B).
We next derived Ptpmt1flox/flox mouse embryonic fibroblasts
(MEFs) from E13.5 embryos obtained from intercrosses of
Ptpmt1+/flox mice. The cells were then infected with control
adenovirus or adenovirus expressing Cre recombinase. The
expression of PTPMT1 protein was almost completely ablated
in the Cre-treated (KO) cells 3 days after the infection and
remained negligible for at least 2 weeks in culture (Figure 1C).
The level of PTPMT1 mRNA transcripts was also greatly dimin-
ished in those cells (Figure S1C).
MEFs lacking PTPMT1 grow slowly. Three days after infection
with Cre recombinase, the proliferation rate of KO cells was
reduced 25% compared to that of control adenovirus-treated
cells (Flox) (Figure S2A). Inhibition of cell growth was more
pronounced in KO MEFs at day 6. A colony formation assay
was also performed to examine the long-term effect of PTPMT1
deficiency on cell growth. Not surprisingly, KO MEFs formed
fewer and smaller colonies than Flox cells (Figures S2B and
S2C). It is noteworthy that Ptpmt1 null cells were not apoptotic
or necrotic (data not shown) and had cell sizes similar to Flox
MEFs (Figure S2D).
The position of PTPMT1 on the inner mitochondrial
membrane places it within close proximity to electron transport
chain complexes and enzymes of the tricarboxylic acid cycle.
Therefore, we investigated the effects of PTPMT1 deletion on
mitochondrial respiration and oxidative phosphorylation. Intact
cell oxygen consumption rates (OCR) were measured at
13 days after deletion of Ptpmt1 (Figure 2A). The basal respira-
tion rates were substantially lower in Ptpmt1 KO cells relative to
that of Flox MEFs. We also assessed state 4 rates (a measure-
ment of proton leakage across the inner membrane) by the
addition of the ATP synthase inhibitor oligomycin, and maximal
respiratory rates by the addition of the uncoupler, carbonylcya-
nide-r-trifluoromethoxyphenylhydrazone (FCCP). A dramatic
reduction in maximal respiratory rates as well as state 4 rates
was observed in the KO cells (Figure 2A), suggesting that
PTPMT1 is required for optimal mitochondrial respiration.
In contrast, when we concomitantly measured the cellular
ATP content, an increase in ATP level was observed in
Ptpmt1-deficient MEFs. The increase was more evident after
preincubation of cells with low glucose medium (Figure 2B),
consistent with our previous report that suppression of
PTPMT1 expression by small-interfering RNA (siRNA) markedly
enhances ATP levels in INS-1 832/13 cells in response to low
glucose exposure (Pagliarini et al., 2005). Mitochondrial oxida-
tive phosphorylation is a major source of cellular ATP produc-
tion; however, it is known that cells can modulate the balance
between aerobic and anaerobic (glycolytic) ATP production
(Warburg, 1956) and that lowering extracellular glucose
enhances glucose transport and utilization (Kletzien and
Perdue, 1975). The diminished mitochondrial respiratory
capacity in the presence of an elevated ATP level prompted
us to hypothesize that glycolysis is increased in Ptpmt1-defi-
cient cells. Therefore, we carried out a time course analysis
of mitochondrial respiration versus glycolysis following lowell Metabolism 13, 690–700, June 8, 2011 ª2011 Elsevier Inc. 691
Figure 2. Inhibition of Mitochondrial Respi-
ration in Ptpmt1-Deficient Cells
(A) Oxygen consumption rates (OCR) of intact
MEFs cultured in regular medium (25 mM glucose)
at 13 dpi. The basal rate, the state 4 rate (with 1 mM
oligomycin, Oligo), and the maximal uncoupler
stimulated rate (in the presence of FCCP) are
shown. Rotenone (Rot) and antimycin A (Anti A)
were used to block all electron flow through
complexes I and III, demonstrating that non-
mitochondrial oxygen consumption in these cells
is negligible. Mean ± SEM from four replicates is
shown.
(B) Whole-cell ATP contents in MEFs (13 dpi)
cultured in regular medium or preincubated with
3 mM glucose containing medium overnight.
Mean ± standard deviation (SD), n = 3, **p < 0.01.
(C and D) Maximal uncoupler stimulated respira-
tion rates (C) and extracellular acidification rate
(ECAR) rates (D) of Ptpmt1-Flox and KO MEFs
preincubated with low glucose (3 mM) media
overnight are obtained at the indicated time post
adenoviral infection. Mean ± SEM from four repli-
cates is shown. **p < 0.01, *p < 0.05.
(E) At 13 dpi, crude mitochondria were isolated
from Flox or KO MEFs, solubilized in b-dode-
cylmaltoside, subjected to BN-PAGE, and
followed by consecutive complex I and complex II
in-gel activity assays. The activities of each
complex are indicated by the appearance of a pink
colored band.
See also Figure S2.
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maximal oxygen consumption rates in Ptpmt1-deficient cells
were not statistically different than those in Flox cells (Fig-
ure 2C). However, significant reduction of maximal respiration
was observed in Ptpmt1-deficient cells 20 days later. Similar
results were obtained in cells cultured in regular growth media
(data not shown). To determine the glycolytic capacity of KO
cells, we measured the rates of extracellular acidification as
an indicator of glycolytic lactate production in Flox and KO
MEFs after low glucose incubation (Parce et al., 1989; Wu
et al., 2007). Indeed, a substantial increase of extracellular
acidification rates (ECAR) was observed in KO MEFs at all
time points, even as early as 4 days after the deletion of Ptpmt1
(Figure 2D). Additionally, when we measured cellular lactate
production levels directly using a colorimetric assay, KO
MEFs displayed a marked increase of lactate at day 13 (Fig-
ure S2E), when the inhibition of mitochondrial respiration was
apparent (Figure 2A). Together, our results show that prolonged
loss of PTPMT1 expression leads to a profound reduction of
mitochondrial maximal respiration, concomitant with an
increase in cellular ATP content. The increase of ATP levels in
KO cells may result from an augmentation of glycolysis,
although we cannot rule out the possibility that the utilization
of ATP was also diminished, particularly since KO MEFs grow
at a much slower rate than Flox cells (Figures S2A–S2C).
To further understand the mechanism by which PTPMT1
reduces mitochondrial respiratory capacity, we isolated mito-692 Cell Metabolism 13, 690–700, June 8, 2011 ª2011 Elsevier Inc.chondria from both Flox and KO MEFs at 13 days after deletion
of the Ptpmt1 gene. The electron transport chain complexes
were separated by blue-native polyacrylamide gel electropho-
resis (BN-PAGE) followed by in-gel activity assays. A NADH:
Nitrotetrazolium blue (NTB) reductase assay was first carried
out to examine the functional integrity of complex I (Figure 2E,
left panel). Under the same assay conditions, a lower band
was also observed, which is likely to be dihydrolipoamide dehy-
drogenase (DLDH) (Yan and Forster, 2009), a component of
multiple mitochondrial dehydrogenases. A profound reduction
of complex I activity was observed in cells lacking PTPMT1,
whereas the DLDH activity remained unchanged. Subsequently,
we determined the activity of complex II by performing a succi-
nate: NTB reductase assay on the same gel strip. In Ptpmt1
null mitochondria, complex II activity was slightly decreased.
(Figure 2E, right panel). Our results demonstrate that PTPMT1
deletion profoundly inhibits the activity of complex I, consistent
with the decreased respiratory rates we observe in those cells.
Together, our results indicate that PTPMT1 is required for mito-
chondrial respiration, likely through its regulation of electron
transport chain complexes.
PTPMT1 Maintains Mitochondrial Membrane Integrity
Wenext examined the effect ofPtpmt1 deletion onmitochondrial
morphology using immunocytochemistry. Cytochrome c stain-
ing of Flox MEFs revealed a typical reticular mitochondrial
network that distributed in a radial manner (Figure 3A, left panel).
Figure 3. PTPMT1 Maintains Mitochondrial Membrane Integrity
(A) Ptpmt1-deficient MEFs have fragmented mitochondria. Two weeks after
deletion of Ptpmt1, cells were stained with anti-cytochrome c antibody and
visualized by immunofluorescence microscopy. DNA was stained blue with
40,6-diamidino-2-phenylindole (DAPI).
(B) Electron micrographs of Flox MEFs. Normal mitochondria with lamellar
cristae are enlarged in the inset. The scale bar represents 1 mm.
(C) EM images of defective mitochondria in KO cells. Inset shows a vesicular
mitochondrion and rupture of the outer mitochondrial membrane/OMM (red
arrow). Red asterisk, loss of cristae and matrix components.
(D) Morphometric analysis of mitochondrial length. Mean ± SEM, n = 80.
(E) Morphometric analysis of cristae/OMM surface area ratio. Mean ± SEM,
n = 52. ***p < 0.001, **p < 0.01.
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pattern, suggesting fragmentation of mitochondria (Figure 3A,
right panel).
In order to further characterize this phenotype, the ultrastruc-
ture of the mitochondria was examined in Flox and KO MEFs by
transmission electron microscopy. As shown in the electron
micrograph in Figure 3B, Flox cells had many normal, elongated
mitochondria with abundant cristae in a lamellar architecture
(inset). In contrast, deletion of Ptpmt1 produced many smaller
mitochondria with a variety of morphological abnormalitiesC(Figure 3C), such as vesicular matrix compartments (inset) with
ruptured outer mitochondrial membranes (red arrow), and
degradation of cristae and matrix components (red asterisk).
Mitochondrial length was subsequently determined by morpho-
metric analysis of electron micrograph images. Not surprisingly,
mitochondria were much shorter in KO cells than those in Flox
cells (Figure 3D), which further supports that loss of PTPMT1
resulted in mitochondrial fragmentation. In addition, the loss of
cristae in KO MEFs was confirmed by morphometric analysis
comparing the ratio of cristae/outer mitochondrial membrane
(OMM) surface area in Flox and KO cells (Figure 3E). Matrix
vesicular formation has been observed in other paradigms of
mitochondrial damage, such as apotosis (Sun et al., 2007).
However, the distortion and deficiency of cristae in KO MEFs
indicated that PTPMT1 is essential for the integrity of the inner
mitochondrial membrane.
Accumulation of PGP in Ptpmt1-Deficient Cells
A full understanding of PTPMT1’s function requires identification
of the endogenous substrate(s) of this phosphatase. Although
initially characterized as a phosphoinositide phosphatase with a
preference for phosphatidylinositol 5-phosphate (PI(5)P) in vitro,
our results indicated that PI(5)P is not likely to be the physiolog-
ical substrate of PTPMT1 (Pagliarini et al., 2004, 2005). In addi-
tion, the poor in vitro activity of PTPMT1 toward proteinaceous
substrates prompted us to employ an unbiased search for a lipid
substrate by comparing cellular phospholipid profiles of Flox and
KO MEFs.
Total lipids from both cells were extracted and subjected to
liquid chromatography followed by tandem mass spectrometry
(MS/MS) analysis. Levels of phosphatidylethanolamine, phos-
phatidylserine, and phosphatidylinositol were comparable in
both Flox and KO MEFs (data not shown). The abundance of
the major phosphatidylglycerophosphate (PGP) species (34:1)
as well as minor forms of PGP were markedly elevated in KO
cells. In contrast, levels of all PGP species were barely detect-
able in Flox MEFs (Figures 4A and 4B; see Figure S3B for the
identification of 34:1 PGP species by MS/MS analysis).
In the 1950s and 1960s, Eugene Kennedy and his coworkers
characterized the biosynthetic pathways for numerous cellular
phospholipids including cardiolipin (Rock, 2008; Vance and
Vance, 2008). In eukaryotes, glycerol-3-phosphate is first acyl-
ated to form phosphatidic acid and then converted to cytidinedi-
phosphate diacylglycerol (CDP-DAG) by the enzyme CDP-DAG
synthase. Subsequent steps in cardiolipin biosynthesis take
place in the inner membrane of mitochondria. These steps
involve the conversion of CDP-DAG to phosphatidylglycerol
(PG) by the sequential action of PGP synthase and a PGP phos-
phatase. Cardiolipin is subsequently produced via condensation
of PGwith CDP-DAG by cardiolipin synthase (Figure 4F). Most of
the biosynthetic enzymes in this pathway have been extensively
studied except the PGP phosphatase whose identity has re-
mained elusive in mammals. Our phospholipid profiling analyses
show that PGP is markedly elevated in KO MEFs, indicating that
PTPMT1 is the mammalian enzyme responsible for the conver-
sion of PGP to PG. If PTPMT1was the phosphatase that dephos-
phorylates PGP, we would expect to find PG levels decreased in
KO cells. As predicted, while several molecular forms of PGwere
identified in the Flox cells (Figure 4C), we observed a substantialell Metabolism 13, 690–700, June 8, 2011 ª2011 Elsevier Inc. 693
Figure 4. Loss of PTPMT1 Leads to the
Accumulation of Phosphatidylglycerophos-
phate In Vivo
(A and B) Mass spectra of PGP in Flox (A) and KO
(B) MEFs 13 days after deletion of Ptpmt1. Insets
of (A) and (B) identified [M-2H]2– ions of 34:1 PGP
(exact mass m/z 413.239) at m/z 413.25, its 13C1
isotope atm/z 413.75, 13C2 isotope atm/z 414.25,
and 34:2 PGP at m/z 412.24. The total number
of carbons and unsaturations in the fatty acyl
chains are listed to indicate the molecular species
of each ion.
(C and D) Mass spectra [M-H]– ions of PG and
[M-2H]2– ions cardiolipin (CL) in Flox and KO
MEFs, respectively. The scales of (C) and (D) are
set at different levels to facilitate the observation of
PG and cardiolipin ions in KO cells.
(E) Ratio of 34:1 PGP to 34:1 PG at the indicated
time after Ptpmt1 deletion.
(F) Schematic diagram of cardiolipin biosynthesis
pathway. PA, phosphatidic acid; CDS, CDP-DAG
synthase; PGS, PGP synthase; CLS, cardiolipin
synthase; TAZ, cardiolipin remodeling enzyme,
Tafazzin. Enzymatic reactions that take place
in mitochondrion are enclosed within the blue
rectangle.
See also Figure S3.
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To further analyze the change in PGP and PG levels induced by
loss of PTPMT1, MEFs were harvested at 3, 6, and 13 days after694 Cell Metabolism 13, 690–700, June 8, 2011 ª2011 Elsevier Inc.Ptpmt1 ablation. The ratio of 34:1 PGP/
PG was determined by mass spectrom-
etry analysis (Figure 4E). Notably, an
increase in the PGP/PG ratio was found
in KO MEFs as early as 3 days after the
deletion of Ptpmt1 (Figure 1C). Moreover,
the PGP/PG ratio was augmented in
a time-dependent manner in KO cells as
compared to that of Flox MEFs. A similar
accumulation of PGP and a reduction of
PG were observed in C2C12 mouse
myoblasts in which PTPMT1 was
knocked down by siRNA in a separate
lipid analysis (data not shown). These
results indicate that PTPMT1 specifically
catalyzes the conversion of PGP to PG
in multiple cell types.
PTPMT1 Dephosphorylates PGP
In Vitro
To determine whether PTPMT1 pos-
sesses PGP phosphatase activity in vitro,
we enzymatically synthesized radiola-
beled PGP. In brief, phosphatidyl-sn-
[U-14C]glycerophosphate (14C-PGP) was
produced by incubating CDP-DAG with
sn-[U-14C] glycerol 3-phosphate in the
presence of purified PGP synthase
(PGS) from E. coli (Dowhan, 1992). Anovernight incubation resulted in the quantitative conversion of
starting materials to 14C-PGP as assessed by thin layer chroma-
tography (TLC) (data not shown).
Figure 5. PTPMT1 Dephosphorylates Phos-
phatidylglycerophosphate In Vitro
(A) Conversion of 14C-labeled PGP to 14C-PG by
recombinant wild-type (WT) versus catalytically
inactive (C132S) PTPMT1. A trace amount of ra-
diolabeled lysoPG was generated during the
reaction.
(B) The specific activities of PTEN, Laforin, DSP21,
and VHR are compared with that of PTPMT1 using
pNPP as the substrate. Mean ± SD, n = 3.
(C) PGP phosphatase activity is not a general
feature of protein tyrosine phosphatases. The
activity of each enzyme using PGP as the
substrate is indicated by the absorbance at
620 nm using malachite green reagents to
measure the release of inorganic phosphate.
Mean ± SD, n = 3.
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PTPMT1. The radioactive reaction products were extracted and
separated by TLC analysis. 14C-labeled PGP remained near the
origin, whereas 14C-PG migrated to the middle of the TLC plate
(Figure 5A), as indicated by the comigration of nonradiolabeled
PG standards (data not shown).While recombinant PTPMT1 effi-
ciently converted PGP to PG in a dose-dependent manner, the
catalytically inactivemutant ofPTPMT1 (C132S) failed tocatalyze
the conversion. Our results demonstrate that PTPMT1 dephos-
phorylates PGP in vitro. To rule out the possibility that the PGP
phosphatase activity is a general feature of the PTP superfamily,
we compared the activity of PTEN, laforin, DSP21, and VHR
against PGP to that of PTPMT1. The specific activity of each
enzyme using pNPP as a substrate is consistent with previously
reported values (Figure 5B) (Denu et al., 1995; Maehama and
Dixon, 1998; Rardin et al., 2008; Worby et al., 2006). PTPMT1
was more efficient at removing phosphate from 14C-PGP than
the other phosphatases (Figure 5C), suggesting that the PGP
phosphatase activity is not a common property shared by PTP
superfamily members. Taken together, our results strongly
suggest that PGP is the physiological substrate of PTPMT1.
PTPMT1 Is Required for Cardiolipin Biosynthesis
As the conversion of PGP to PG is an integral part of the de novo
cardiolipin biosynthetic pathway, we predict that loss of PTPMT1
would lead to a reduction in cardiolipin content in the cells. Car-
diolipin is one of the major components of the mitochondrial
inner membrane (Daum, 1985). It optimizes mitochondrial respi-
ration through its interactions with electron transport chain
complexes and multiple carrier proteins including the adenine
nucleotide transporter, as well as stabilizing the supercomplex
formation of respiratory enzymes (Hatch, 1998; Houtkooper
and Vaz, 2008; Schlame et al., 2000). As such, it is understand-
able that Ptpmt1-deficient cells would have profound defects in
mitochondrial respiratory capacity and inner mitochondrial
membrane morphology due to cardiolipin deficiency.Cell Metabolism 13, 690–Notably, our mass spectrometry anal-
ysis of phospholipids revealed a marked
decrease in cardiolipin (CL) content in
KO MEFs 13 days after deletion of
Ptpmt1 (Figures 4C and 4D). Moreover,both the content and the acyl chain composition of cardiolipin
were altered in KO cells. To further quantify the effect of PTPMT1
on cardiolipin metabolism, we next determined the steady-state
phospholipid composition of Flox versus KO MEFs by labeling
intact cells with 32P-orthophosphate. Two weeks after Cre
recombinase infection, cardiolipin and PG levels in KO MEFs
were reduced to 36% and 39% of those in Flox cells, respec-
tively (Table 1), indicating that PTPMT1 is required for the biosyn-
thesis of both lipids. Notably, the abundance and composition of
cardiolipin remained indistinguishable in Flox and KO MEFs at 3
and 6 days afterPtpmt1 deletion (Figures S3C and S3D), which in
turn explained why the mitochondrial oxygen consumption rates
were not reduced in KO cells at early time points (Figure 2C). The
time-dependent loss of cardiolipin in KO cells may reflect the
slow turnover rate of this mitochondrial lipid, which may be influ-
enced by a combination of factors, including degradation and re-
cycling (Schlame, 2008). It is important to note that the relative
abundance of phosphatidic acid, phosphatidylcholine, phos-
phatidylethanolamine, phosphatidylserine, and phosphatidyli-
nositol were not affected by the loss of PTPMT1 (Table 1). The
level of sphingomyelin was decreased to a lesser extent in the
KO MEFs. The physiological significance of this reduction
remains unclear. Collectively, our data demonstrate that
PTPMT1 is required for cardiolipin biosynthesis, consistent
with its function as the PGP phosphatase.
The Catalytic Activity of PTPMT1 Is Essential
for Cardiolipin Synthesis
To verify that the catalytic activity of PTPMT1 is required for
cardiolipin biosynthesis, we next examined whether wild-type
or a phosphatase inactive mutant (C132S) of PTPMT1 is able
to rescue the mitochondrial defects in KO cells. One week after
deletion of Ptpmt1, MEFs were infected with recombinant
adenoviruses encoding b-galactosidase (LacZ), wild-type, or
mutant PTPMT1. Cardiolipin content and mitochondrial respira-
tion were subsequently analyzed after rescuing for 7 days. Both700, June 8, 2011 ª2011 Elsevier Inc. 695
Table 1. Phospholipid Composition of Ptpmt1 Flox and KO MEFs
Percent of Total Phospholipids
Flox KO
Cardiolipin 2.8 ± 0.2 1.0 ± 0.3***
Phosphatidylglycerol 1.8 ± 0.3 0.7 ± 0.2**
Phosphatidic acid 1.6 ± 0.3 1.5 ± 0.4
Phosphatidylcholine 39.9 ± 2.0 45.1 ± 2.4
Phosphatidylethanolamine 28.1 ± 0.6 28.1 ± 0.5
Phosphatidylserine 11.0 ± 1.0 10.3 ± 1.4
Phosphatidylinositol 11.2 ± 0.5 10.7 ± 0.3
Sphingomyelin 3.7 ± 0.3 2.6 ± 0.4*
After 13 days of adenoviral infection, cells were cultured in the medium
containing 32Pi (1uCi/ml) for 4 days. Total cellular phospholipids were
extracted and analyzed as described in the Experimental Procedures.
Data shown are the mean ± SEM for three independent experiments
and are statistically analyzed with a Student’s t test. ***p < 0.001,
**p < 0.01, *p < 0.05 between Flox and KO MEFs.
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(Figure 6A), but expression of the CS mutant severely impaired
the cell growth of KO MEFs (data not shown). Nonetheless,
we examined steady-state phospholipid composition. The
abundance of cardiolipin was greatly diminished in KO MEFs
expressing LacZ, compared to that of the LacZ-expressing
Flox cells (Figure 6B), consistent with our earlier observation
(Table 1). Interestingly, overexpression of wild-type PTPMT1
partially restored the cardiolipin content of KOMEFs. In contrast,
the cardiolipin level was further decreased in KO cells expressing
the CS mutant, suggesting that the catalytic activity of PTPMT1
is important for cardiolipin biosynthesis. Given the dramatic
alteration of mitochondrial morphology in KO cells, it is conceiv-
able that overexpression of wild-type PTPMT1 may not be
able to fully reverse the structural defect and cardiolipin
deficiency in the time frame of our experiment. Moreover, the
abundance of PGP was simultaneously examined by TLC
analysis (Figure 6C). PGP was barely detectable in Flox cells,
whereas a distinct PGP band was found in KO MEFs expressing
LacZ, as indicated by the comigration of 14C-labeled PGP. As
expected, wild-type PTPMT1 alleviated the accumulation of
PGP in KO cells. In contrast, overexpression of the PTPMT1
CS mutant in Ptpmt1 null cells substantially augmented cellular
PGP content, suggesting that this mutant protein may function
as a trap to accumulate PGP. Similar ‘‘substrate-trapping’’
mutants have been studied in many members of PTP family to
stabilize and identify their endogenous targets (Tonks and
Neel, 2001). In contrast, the CS mutant had a minimal effect on
the levels of cardiolipin and PGP in Flox cells, probably because
the endogenous PTPMT1 can efficiently convert PGP to PG.
To rescue the mitochondrial defects in Ptpmt1-deficient cells,
we next overexpressed either wild-type or mutant PTPMT1
and measured mitochondrial respiration rates of those cells
(Figure 6D). As anticipated, intact cell oxygen consumption
rates were much slower in LacZ-expressing KO MEFs,
compared to that of Flox cells. Wild-type PTPMT1 partially
reversed the inhibition of mitochondrial respiration in Ptpmt1
null cells, whereas CS mutants failed to rescue the phenotype.
Together, our results indicate that the catalytic activity of696 Cell Metabolism 13, 690–700, June 8, 2011 ª2011 Elsevier Inc.PTPMT1 is indeed essential for cardiolipin synthesis and mito-
chondrial function.
PTPMT1 Functionally Replaces Yeast PGP
Phosphatase Gep4
Putative PTPMT1 orthologs have been identified in a variety of
evolutionarily distinct species, except the budding yeast
S. cerevisiae (Pagliarini et al., 2004). Osman et al. recently
reported that Gep4 functions as a PGP phosphatase in yeast
mitochondria (Osman et al., 2010). Gep4 is a member of the
haloacid dehydrogenase superfamily and is present only in fungi
and plants. Therefore, we sought to determine whether PTPMT1
serves as a functional equivalent of Gep4 in yeast.
FLAG-tagged Gep4, wild-type PTPMT1, or mutant PTPMT1
was first transformed into GEP4 null strain, and the expression
was confirmed by western blot analysis (Figure 6E, bottom two
panels). PTPMT1 contains an N-terminal mitochondrial targeting
sequence (Pagliarini et al., 2005), which we hypothesized would
also direct PTPMT1 to the yeast mitochondria. Indeed, our
subcellular fractionation analysis indicated that PTPMT1 prefer-
entially accumulated in the yeast mitochondria similar to Gep4
(data not shown). Consistent with the observation by Osman
et al., the yeast strain that lacks GEP4 did not grow at 37C on
glucose-containing medium (Figure 6E, second panel). Both
Gep4 and wild-type PTPMT1 efficiently rescued the temperature
sensitive growth defects. However, the PTPMT1 CS mutant
failed to complement the loss of GEP4. In addition, gep4D cells
were unable to grow in the presence of ethidium bromide, an
agent that induces loss of mitochondrial DNA and defects in
cell wall (Janitor and Subı´k, 1993; Zhong et al., 2005). Notably,
overexpression of wild-type PTPMT1 greatly improved the
growth of gep4D cells in ethidium bromide containing medium,
similar to that of Gep4-expressing cells (Figure 6E, third panel).
Our lipid analysis indicated that wild-type but not mutant
PTPMT1 rescued the cardiolipin deficiency of gep4D cells (Fig-
ure S4). Together, our results demonstrate that PTPMT1
complements the loss ofGEP4 in yeast and this rescue is depen-
dent on the phosphatase activity of PTPMT1.
DISCUSSION
Over 100 human genes have been identified belonging to the
PTP superfamily, all of which contain a highly conserved CX5R
motif in the active site for catalysis (Alonso et al., 2004; Tonks,
2006). Most members of the PTP family are key mediators of
signal transduction through their dephosphorylation of proteins
and phosphoinositides (Tonks, 2006). The unique subcellular
localization of PTPMT1 prompted us to investigate whether it
plays an important role in mitochondrial signaling. In the present
study, we discovered that PTPMT1 dephosphorylates PGP,
a glycerophospholipid, and is essential for mitochondrial
function through its regulation of cardiolipin biosynthesis. Our
findings strongly suggest that phosphatases in the PTP family
can be involved in cellular processes other than signal trans-
duction. It will be of interest to determine whether some of the
less characterized PTP family members target unorthodox
substrates like PTPMT1.
The enzyme reaction catalyzed by the PGP phosphatase was
first characterized by Kennedy et al. in 1963 using rat and
Figure 6. Wild-Type but Not an Active
Site Mutant PTPMT1 Rescues Cardiolipin
Deficiency
(A) The expression of b-galactosidase (LacZ), wild-
type PTPMT1 (MT1), or catalytically inactive
PTPMT1 mutant (CS).
(B) After labeling of MEFs with 32P-orthophos-
phate, phospholipids were extracted and the
percentage of cardiolipin (CL) among total
phospholipids was determined by TLC analysis.
Mean ± SEM from three independent ex-
perimentsis shown. One-way ANOVA with a post
hoc F test, ***p < 0.001, **p < 0.01.
(C) The accumulation of PGP in Ptpmt1-deficient
cells. For each sample, 50,000 cpm of 32P-labeled
phospholipids were applied onto TLC plates and
visualized by phosphoimager.
(D) Oxygen consumption rates of intact MEFs
cultured in regular medium. The basal rate, the
state 4 rate (Oligo), and the maximal uncoupler
stimulated rate (FCCP) are shown as described in
Figure 2. Mean ± SEM from four replicates is
shown.
(E) Wild-type but not mutant PTPMT1 comple-
ments the growth deficiency of yeast PGP
phosphatase GEP4 null (gep4D) cells in a serial
dilution spotting assay. The expression levels of
FLAG-tagged Gep4 and PTPMT1 are indicated by
western blot analysis. The level of Cdc2 is shown
as a control. WT, wild-type strain; –, empty vector;
SCD, synthetic complete medium with dextrose;
EtBr, ethidium bromide.
See also Figure S4 and Table S1.
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which is conserved in bacteria, is catalyzed by PgpA, PgpB,
and the recently identified PgpC, three bacterial enzymes that
display no homology to PTPMT1 (Icho and Raetz, 1983; Lu
et al., 2011). Osman et al. recently reported that Gep4 dephos-
phorylates PGP in yeast (Osman et al., 2010). Gep4 is a member
of the haloacid dehydrogenase superfamily which contains
a DxDx(T/V) motif in the active site and utilizes a unique Asp-
based catalytic mechanism (Kerk et al., 2008). Gep4 orthologs
exist in fungi and plant, but are not found in higher eukaryotes,
providing little insight into the identity of the mammalian
PGP phosphatase. On the other hand, PTPMT1 is one of the
most widely distributed and highly conserved PTPs, with
over 60 orthologs identified in Animalia, Plantae, Protista,
and Eubacteria (Pagliarini et al., 2004), which raises the
possibility that PTPMT1 orthologs also utilize PGP as their
substrates. Although a PTPMT1-like sequence is not present in
Saccharomyces cerevisiae, our results demonstrate that
mammalian PTPMT1 serves as a functional equivalent of Gep4
in yeast (Figure 6E). PTPMT1, Gep4, PgpA, PgpB, and PgpC
are structurally and evolutionarily distinct enzymes with distinct
regulatory mechanisms for their activities (Table S2) (Kerk
et al., 2008; Kumaran et al., 2006; Pagliarini et al., 2004; StukeyCell Metabolism 13, 690–and Carman, 1997). Why nature has
utilized such divergent phosphatases to
remove the phosphate from PGP is
presently unclear, but it may reflectfundamental differences among organisms to regulate cardioli-
pin synthesis and possibly energy metabolism.
Substantial accumulation of PGPwas observed in cells lacking
PTPMT1 (Figure 4B). Notably, PGP exists in cells at low abun-
dance (Kiyasu et al., 1963; MacDonald and McMurray, 1980).
Little is known about the function of PGP in cells other than it is
an intermediate in the cardiolipin biosynthetic pathway.
However, we found that depletion of PTPMT1 not only inhibited
cell growth (Figures S2A–S2C), but also led to an increase in
cellular ATP content and glycolysis (Figures 2B and 2D). This
phenomenon was observed even before the onset of cardiolipin
deficiency (Figures S3C and S3D) and inhibition of mitochondrial
respiratory capacity (Figure 2C), implying a possible role for PGP
or other intermediates of the pathway in the regulation of aerobic
and anaerobic metabolism. It will be interesting to determine
whether deletion of Ptpmt1 alters the activity of glycolytic
enzymes or the abundance of glycolytic intermediates as a result
of PGP accumulation. Indeed, several enzymes of the glycolytic
pathway have been found associated with mitochondrial
membranes, such as hexokinase on the outer membrane (Wil-
son, 2003) and FAD-linked glycerol-3-phosphate dehydroge-
nase on the inner membrane (Klingenberg, 1970). In addition, it
is likely that the rate of energy utilization is diminished in the700, June 8, 2011 ª2011 Elsevier Inc. 697
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all increaseof cellular ATPcontent. Further investigation of glyco-
lytic intermediates, glycolytic rates, andATPconsumption inboth
Flox and KOMEFs is clearly warranted and is ongoing in our lab.
Our results found that Ptpmt1–/– embryos implanted but died
prior to E8.5, suggesting an essential role for the Ptpmt1 gene
during early embryonic development. However, the cause of
embryonic lethality is not fully understood. It is noteworthy that
the demand for mitochondria varies at different embryonic
developmental stages. In the early embryo, mitochondria are
maternally inherited and their population remains relatively
constant until after implantation, when rapid mitochondrial
biogenesis and mitochondrial DNA replication resume in
response to the increasing demand for energy production during
organogenesis (Cerritelli et al., 2003; Van Blerkom, 2009; Hance
et al., 2005; Larsson et al., 1998). Therefore, it is possible that
PTPMT1 is required for the increased mitochondrial biogenesis
that occurs in postimplantation embryos.
Identifying the mammalian PGP phosphatase is of interest not
only because it is a missing step of lipid biosynthesis, but also
due to its potential implication in many cardiolipin deficiency-
related diseases, such as ischemia/reperfusion injury, heart
failure, aging, and neurodegeneration (Chicco and Sparagna,
2007; Houtkooper and Vaz, 2008). It is noteworthy that the reac-
tive cysteine in PTP family phosphatases is highly susceptible to
oxidative stress (Tonks, 2005). PTPMT1 is tethered to the inner
mitochondrial membrane, where its activity could be regulated
by mitochondrial reactive oxygen species (ROS). Loss of two
copies of the Ptpmt1 gene in all tissues is embryonic lethal;
however, a single copy of a functional Ptpmt1 gene could result
in an organism being highly susceptible to episodes of oxidative
stress. Furthermore, loss of cardiolipin content in mitochondria
has been well documented in cardiac ischemia/reperfusion
injury (Chicco and Sparagna, 2007), but the underlyingmolecular
mechanism is poorly understood. Hence, our identification of
a potentially redox-sensitive enzyme in the cardiolipin synthesis
pathway raises the question of whether inactivation of PTPMT1
bymitochondrial ROS contributes to cardiolipin deficiency under
those conditions.
In conclusion, our work has identified the substrate of PTPMT1
by comparing phospholipid analyses coupled with mass spec-
trometry of lipids extracted fromwild-type versus knockout cells.
These analyses provided us with the key to understanding the
biological functions of PTPMT1 within mitochondria. This
approach can be applied to understanding the molecular mech-
anisms underlying other alterations in phospholipid metabolism.
Finally, in addition to the discovery of a lipid biosynthetic
enzyme, we demonstrated that PTPMT1 functions as an impor-
tant regulator of mitochondrial physiology, which may provide
perspectives into the etiology of many mitochondria defi-
ciency-related diseases.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
MEFs and C2C12 mouse myoblast cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% FBS, 100 units/ml penicillin,
100 mg/ml streptomycin, and 2 mM glutamine and were cultured at 37C in
a humidified incubator with 5% CO2. The expression and purification of
recombinant PTPMT1, PTEN, laforin, DSP21, and VHR were previously698 Cell Metabolism 13, 690–700, June 8, 2011 ª2011 Elsevier Inc.described (Denu et al., 1995; Maehama and Dixon, 1998; Pagliarini et al.,
2004; Rardin et al., 2008; Worby et al., 2006). 1,2-dioleoyl-sn-glycerol-3-
cytidine diphosphate (ammonium salt) and 1,2-dioleoyl-sn-glycero-3-phos-
pho-(10-rac-glycerol) (sodium salt) were purchased from Avanti Polar Lipids
(Alabaster, AL), DL-a-glycerol phosphate dipotassium salt was from Sigma,
and sn-[U-14C] glycerol 3-phosphate disodium salt was from American Radio-
labeled Chemicals (Saint Louis, MO).
Mice
Generation of Ptpmt1 knockout mice is described in the Supplemental Exper-
imental Procedures. All procedures were performed in accordance with the
National Institutes of Health (NIH) Guide for the Care and Use of Laboratory
Animals and approved by the Institutional Animal Care and Use Committee
of University of California San Diego.
Derivation and Adenoviral Infection of MEFs
MEFs from E13.5 embryos from intercrossed of Ptpmt1+/flox mice were
isolated, cultured, genotyped, and immortalized. For transduction of
Ptpmt1flox/flox fibroblasts with the Cre recombinase, cells were infected with
adenoviruses encoding either GFP or GFP-Cre (Gene transfer vector core,
University of Iowa). Adenoviral vectors containing untagged wild-type or
C132S mutant of murine PTPMT1 were constructed into pAd/CMV/V5-DEST
vector (Invitrogen), and adenoviruses were generated and purified. pAd/
CMV/V5-GW/lacZ (Invitrogen) was used as the control.
Western Blot and Immunofluorescence Analysis
The western blots were performed with antibodies against PTPMT1 (Pagliarini
et al., 2005), VDAC1 (Calbiochem), FLAG M2 (Sigma), and Cdc2 (Santa Cruz).
For immunofluorescent staining, MEFs were plated on glass coverslips, fixed
with 3.7% formaldehyde and then incubated with anti-cytochrome c (BD
Biosciences) antibody and Alexa Fluor 488 goat anti-mouse-conjugated
secondary antibody (Molecular Probes). Nuclei were stained with 40,6-diami-
dino-2-phenylindole (DAPI, Molecular Probes).
Liquid Chromatography/Tandem Mass Spectrometry Analysis
Total cellular phospholipids were extracted (Bligh and Dyer, 1959) and quan-
tified with normal phase Liquid Chromatography coupled to a QSTAR XL
tandem mass spectrometer (Applied Biosystems, Foster City, CA) equipped
with an electrospray source (see the Supplemental Experimental Procedures
for details). Data acquisition and analysis were performed with the instru-
ment’s Analyst QS software.
PGP Phosphatase Assay
14C-labeled PGP was synthesized as described (Dowhan, 1992). The PGP
phosphatase activities of recombinant PTPMT1, PTEN, Laforin, DSP21, and
VHR were determined by TLC or malachite green analysis (see the Supple-
mental Experimental Procedures).
Phospholipid Quantification
Cellular phospholipids were extracted (Bligh and Dyer, 1959) and separated by
TLC with Chloroform/Methanol/ammonium hydroxide/water (130:75:2:6). For
the separation of PGP, ethylacetate/2-propanol/ethanol/6% ammonia
(3:9:3:9) was used as TLC solvent (Osman et al., 2010). Individual species
were identified by comigration of nonradiolabeled standards. Their relative
intensities were analyzed with the Typhoon 9410 Variable Mode Imager and
ImageQuant TL software (GE Healthcare Life Science).
Mitochondrial Functional Analyses
Oxygen consumption (OCR) and extracellular acidification rates (ECAR) were
measured with a Seahorse Extracellular Flux Analyzer XF24 (Seahorse Biosci-
ence, North Billerica, MA) (Wu et al., 2007). Forty thousand cells were plated
into each well prior to the assay. OCR and ECAR were normalized by the
DNA content. (See the Supplemental Experimental Procedures for details.)
The data were presented as the means ± standard error of the mean (SEM)
for four replicates. Qualitatively similar results were obtained in three separate
experiments. Differences in rates were analyzed by one-way ANOVA with
a post hoc F test. For measurement of cellular ATP content, MEFs were plated
and grown overnight in regular or low glucose (3 mM) media, and whole-cell
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Assay kit (Promega) and normalized by DNA content. Statistical analysis
was performed via one-way ANOVA with a post hoc F test. Cellular lactate
was measured by a colorometric assay kit (Abcam) and normalized by total
protein amount. Differences between Flox and KO MEFs were examined for
statistical significance with a Student’s t test.
Blue-Native PAGE
Subconfluent MEFs were harvested and crude mitochondria were isolated by
differential centrifugation (Pallotti and Lenaz, 2001). Twenty micrograms of
mitochondria were solubilized on ice with 1% b-dodecylmaltoside (Invitrogen)
for 30 min and further separated by 4%–16% Native PAGE gel (Invitrogen)
(Scha¨gger and von Jagow, 1991; McKenzie et al., 2007). For assessment of
the activity of complex I, the gel was incubated in 2 mM Tris/HCl (pH 7.4)
containing 0.1 mg/ml NADH and 2.5 mg/ml nitrotetrazolium blue (Zerbetto
et al., 1997). Subsequently, the gel was incubated in 2 mM Tris/HCl (pH 7.4)
buffer in the presence of 20mM sodium succinate, 2 mMphenazinemethosul-
fate, and 2.5mg/ml nitrotetrazolium blue for the complex II in-gel activity assay
(Wittig et al., 2007).
Transmission Electron Microscopy and Morphometric Analysis
Cells were grown on 35 mm glass bottom culture dishes (MatTek, Ashland,
MA). Sample preparation and conventional EM analysis were carried out as
described in the Supplemental Experimental Procedures. Mitochondrial
lengths and cristae/OMM surface area ratio were measured using ImageJ
(NIH). Differences between Flox and KO MEFs were examined for statistical
significance with a Student’s t test.
Yeast Complementation Assays
Yeast strains used in this study are derivatives of S288C (Brachmann et al.,
1998).GEP4 knockout strains are obtained fromOpenBiosystems and verified
by gene-specific PCR primer pairs. The plasmids for complementation
assays in yeast were constructed by inserting the PCR products of GEP4,
M. musculus PTPMT1 (wild-type), and mutant PTPMT1 (C132S) with
C-terminal FLAG tag into pRS415-GPD vector (ATCC). Subsequently, gep4D
cells were transformed with plasmids containing GEP4, PTPMT1, or empty
vector. Cells were grown in the appropriate selective medium at 30C to
mid-log phase and counted, followed by 5-fold serial dilution. Each dilution
was spotted onto either YPD plates or Synthetic Completed Medium with
Dextrose (SCD) in the presence of 25 mg/ml ethidium bromide, and cultured
at the indicated temperature for 2 days.
Full experimental procedures and associated references are enclosed in the
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
doi:10.1016/j.cmet.2011.04.007.
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